Flow Cytometry Analysis of CD5+ B Cells: A Frame of Reference for Minimal Residual Disease Analysis in Chronic Lymphocytic Leukemia

American Journal of Clinical Pathology

Volumn 121, Issue 3, 2004, Pages 368-372

  Gupta, Ritu ^a   Jain, Paresh ^a,b   Deo, S V S ^a   Sharma, Atul ^a  

^a INSTITUTE ROTARY CANCER HOSPITAL   (India)

^b Azad Apartments   (India)

Author keywords

CD5+ B cells; Chronic lymphocytic leukemia; Flow cytometry; Minimal residual disease

Indexed keywords

CD19 ANTIGEN; CD5 ANTIGEN; FLUORESCEIN ISOTHIOCYANATE; PHYCOERYTHRIN;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BONE MARROW; CANCER SCREENING; CHRONIC LYMPHATIC LEUKEMIA; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LEUKEMIA CELL; LEUKOCYTE; MINIMAL RESIDUAL DISEASE; NORMAL HUMAN; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; BLOOD; COMPARATIVE STUDY; CYTOLOGY; IMMUNOLOGY; METABOLISM; METHODOLOGY; MIDDLE AGED; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD5; B-LYMPHOCYTES; BONE MARROW; FLOW CYTOMETRY; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MIDDLE AGED; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 1542377672     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/T5EM-9BQU-B9CM-8F57     Document Type: Article

References (18)

1. Cheson BD, Bennett JM, Grever M, et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood. 1996;87:4990-4997.
2. Cabezudo E, Matutes E, Ramrattan M, et al. Analysis of residual disease in chronic lymphocytic leukemia by flow cytometry. Leukemia. 1997;11:909-914.
3. Pfitzner T, Engert A, Wittor H, et al. A real-time PCR assay for the quantification of residual malignant cells in B cell chronic lymphatic leukemia. Leukemia. 2000;14:754-766.
4. Rawstron AC, Kennedy B, Evans PA, et al. Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy. Blood. 2001;98:29-35.
5. Vuillier F, Claisse JF, Vandenvelde C, et al. Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone marrow remission using CD5-CD19 markers and PCR study of gene rearrangements. Leuk Lymphoma. 1992;7:195-204.
6. Bournsell L, Bernard A, Lepage V, et al. Some chronic lymphocytic leukemia cells bearing surface immunoglobulins share determinants with T cells. Eur J Immunol. 1978;8:900-904.
7. Kipps TJ, Vaughan JH. Genetic influence on the levels of circulating CD5 B lymphocytes. J Immunol. 1987;139:1060-1064.
8. Kipps TJ. The CD5 B cell. Adv Immunol. 1989;17:117-185.
9. Maloum K, Sutton L, Baudet S, et al. Novel flow-cytometric analysis based on BCD5+ subpopulations for the evaluation of minimal residual disease in chronic lymphocytic leukaemia. Br J Haematol. 2002;119:970-975.
10. Sanchez ML, Almeida J, Vidriales B, et al. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color staining to be used for minimal residual disease investigation. Leukemia. 2002;16:1460-1469.
11. Matutes E, Morillo R, Catovsky D. Immunophenotyping. In: Lewis SM, Bain BJ, Bates I, eds. Dacie and Lewis Practical Haematology. 9th ed. London, England: Churchill Livingstone; 2001:297-314.
12. Vuillier F, Scott-Algara D, Dighiero G. Extensive analysis of lymphocyte subsets in normal subjects by three-color immunofluorescence. Nouv Rev Fr Hematol. 1991;33:31-38.
13. Tung JW, Kunnavatana SS, Herzenberg LA, et al. The regulation of CD5 expression in murine T cells. BMC Mol Biol. 2001;2:5.
14. Lenormand B, Bizet M, Fruchart C, et al. Residual disease in B-cell chronic lymphocytic leukemia patients and prognostic value. Leukemia. 1994;8:1019-1026.
15. Antin JH, Ault KA, Rappeport JM, et al. B lymphocyte reconstitutio after human bone marrow transplantation: Leu-1 antigen defines a distinct population of B-lymphocytes. J Clin Invest. 1987;80:325-332.
16. Lavabre-Bertrand T, Janossy G, Exbrayat C, et al. Leukemia-associated changes identified by quantitative flow cytometry, II: CD5 over-expression and monitoring in B-CLL. Leukemia. 1994;8:1557-1563.
17. Rawstron AC, Green MJ, Kuzmicki A, et al. Monoclonal B lymphocytes with the characteristics of "indolent" chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood. 2002;100:635-639.
18. Rawstron AC, Yuille MR, Fuller J, et al. Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion. Blood. 2002;100:2289-2290.